Boston Scientific (BSX) Assets Average (2009 - 2026)

Boston Scientific (BSX) has 18 years of Assets Average data on file, last reported at $44.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 10.67% year-over-year to $44.0 billion; the trailing twelve-month figure through Mar 2026 stood at $44.0 billion (up 10.67% YoY), and the FY2025 full-year result was $41.5 billion, up 11.45% from the prior year.
• Assets Average rose to $44.0 billion in Q1 2026, from $43.2 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $44.0 billion in Q1 2026 to a low of $32.1 billion in Q3 2022.
• A 5-year average of $36.6 billion and a median of $35.9 billion in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average grew 0.48% in 2022 and rose 12.08% in 2025, its largest moves.
• Tracing BSX's Assets Average over 5 years: stood at $32.2 billion in 2022, then increased by 7.39% to $34.6 billion in 2023, then rose by 11.99% to $38.7 billion in 2024, then advanced by 11.5% to $43.2 billion in 2025, then rose by 1.9% to $44.0 billion in 2026.
• Business Quant data shows BSX's Assets Average at $44.0 billion in Q1 2026, $43.2 billion in Q4 2025, and $42.1 billion in Q3 2025.